Physician profile
David B Owen
NPI 1386621365
$4,206.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,431 · 2020: $1,274 · 2021: $477 · 2024: $23.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $850.09 | 2019-2020 | |
| Greenwich Biosciences, INC. | $690.74 | 2019-2021 | |
| Eisai INC. | $576.45 | 2019-2021 | |
| Tris Pharma INC | $448.56 | 2019-2021 | |
| Ucb, INC. | $392.65 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $286.28 | 2019-2020 | |
| Sk Life Science, INC. | $257.99 | 2020-2021 | |
| Aquestive Therapeutics, INC. | $145.00 | 2019-2021 | |
| Neos Therapeutics, LP | $99.37 | 2020 | |
| Neurelis, INC. | $98.25 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $82.05 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $62.71 | 2019 | |
| Livanova USA, INC. | $41.75 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $35.79 | 2020 | |
| Shire North American Group INC | $29.06 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.80 | 2024 | |
| Biomarin Pharmaceutical INC. | $23.63 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.16 | 2020 | |
| Allergan, INC. | $15.82 | 2019 | |
| Cranial Technologies, INC | $14.30 | 2021 | |
| Mallinckrodt Enterprises LLC | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.